News about Global Pharma

Wheeler Bio Plans for Expansion with Closing of Oversubscribed Series A-1 Financing Round

The USD 35 million round was led by Alloy Therapeutics and Echo Investment Capital (Echo), with participation from Mitsubishi Corporation (Americas), Germin8 Ventures, and Russell Westbrook Enterprises.

Global Pharma | 25/03/2025 | By Aishwarya |  317

Chang Gung Memorial Hospital Leads Taiwan with 12,000+ Robotic Surgeries

By the end of 2024, the hospital had performed over 12,000 robotic surgeries, accounting for one-sixth of Taiwan's robotic procedures and cementing its leadership in the field. With its technical expertise and clinical achievements, Chang Gung is steering Taiwan into a new era of minimally invasive surgery worldwide with its robust healthcare system.

Global Pharma | 24/03/2025 | By Manvi |  229

SMS Pharma Announces Successful Completion of USFDA Inspection at Hyderabad API Facility

SMS Pharmaceuticals has successfully completed a USFDA inspection at its Bachupally API facility in Hyderabad, receiving one procedural observation with no impact on data integrity or product quality.

Global Pharma | 24/03/2025 | By Manvi |  729

Sanofi to Acquire Dren Bio Bispecific Myeloid Cell Engager for Deep B-Cell Depletion

DR-0201 is a potential first-in-class CD20-directed bispecific antibody that targets and engages specific tissue-resident and trafficking myeloid cells to induce deep B-cell depletion via targeted phagocytosis.

Global Pharma | 24/03/2025 | By Aishwarya |  260

BrePco and Piramal Receive UK MHRA Approval for Neoatricon Paediatric Dopamine Formula

Neoatricon, developed by BrePco Biopharma, is an age-appropriate, ready-to-use, sterile solution available in two concentrations: 1.5 mg/mL in a 30 mL vial and a higher strength of 4.5 mg/mL in a 50 mL vial.

Global Pharma | 24/03/2025 | By Aishwarya |  355

Syneron Bio Signs Strategic Partnership with AstraZeneca

Under this collaboration, AstraZeneca will gain access to Syneron Bio's innovative Synova™ platform, an intelligent and high-throughput macrocyclic peptide drug research and development platform, designed to support the advancements of research programmes exploring possible future treatments of chronic diseases.

Global Pharma | 24/03/2025 | By Aishwarya |  1049

Hansoh Pharma Expands Indications for Merigolix with Initiation of ART Development

Hansoh Pharma recently received approval for an IND (Investigational New Drug) application targeting ART, expanding the development area of merigolix.

Global Pharma | 21/03/2025 | By Aishwarya |  505

Pint Pharma Gets ANVISA Approval of BESREMi for Polycythemia Vera

Polycythemia Vera (PV) is a rare, chronic, debilitating, and potentially fatal myeloproliferative neoplasm, originating from a disease-initiating stem cell in the bone marrow.

Global Pharma | 21/03/2025 | By Aishwarya |  607

Grifols and Inpeco to Deliver Transfusion Medicine Labs

Grifols, whose technology analyzes tens of millions of donor samples each year, now complements its portfolio with Inpeco’s new open automation system FlexLab™ X, a combination of leading-edge robotics and software that will enable Grifols solutions to interconnect with, and expand within, existing and future lab footprints.

Global Pharma | 21/03/2025 | By Aishwarya |  263

Advanced Instruments Plans to Acquire and Merge Nova Biomedical

Following the closing of the transaction, Advanced Instruments and Nova Biomedical will merge, creating a global life science tools platform that will operate under the Nova Biomedical name, with a diversified portfolio of analytical instruments, reagents and services.

Global Pharma | 20/03/2025 | By Aishwarya |  377